Inventionmed SA
WSE:INM
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| PL |
I
|
Inventionmed SA
WSE:INM
|
22.8m PLN |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.5B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.1B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD |
Loading...
|
Market Distribution
| Min | -9 940 700% |
| 30th Percentile | -3.7% |
| Median | 2.9% |
| 70th Percentile | 9.1% |
| Max | 196 605.3% |
Other Profitability Ratios
Inventionmed SA
Glance View
InventionMed SA engages in the research and development in the area of medical training. The company is headquartered in Bydgoszcz, Woj. Kujawsko - Pomorskie. The company went IPO on 2013-03-25. The firm is focused on developing TutorDerm, an advanced medical simulator based on virtual reality (VR) technology for the purpose of training doctors, medical students and cosmetologists in conducting dermatological procedures.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Inventionmed SA is -110.2%, which is above its 3-year median of -1 073 407.5%.
Over the last 3 years, Inventionmed SA’s Net Margin has increased from -9 496% to -110.2%. During this period, it reached a low of -7 042 400% on Jun 30, 2023 and a high of -110.2% on Oct 30, 2025.
